All News

Orthopaedic Surgeon, Dr. Jeffrey Carlson, first in Central and Eastern Virginia to implant the M6-C Artificial Cervical Disc

Dr. Jeffrey Carlson has been a part of Orthopaedic & Spine Center since 1999 and serves as the President and Managing Partner. He is a board-certified, fellowship-trained orthopaedic surgeon who focuses on the treatment of injuries and disorders of the spine. NEWPORT NEWS, Va., Dec. 18, 2019 /PRNewswire/ — Orthopaedic and Spine Center announced Dr. Jeffrey Carlson, Orthopaedic …

Biogennix Reports Record Year for Sales

IRVINE, Calif. — December 18, 2019 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone grafting products used for bone fusion procedures, announced today that 2019 has been its best sales year in company history. Also, the company announced that the fourth quarter of 2019 (current quarter) has already been the …

SeaSpine Announces 25,000th NanoMetalene® Implantation

CARLSBAD, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 25,000th NanoMetalene® interbody device. NanoMetalene is a proprietary surface technology for interbody implants that incorporates a sub-micron layer of commercially pure titanium …

Aurora Spine Announces New Chief Financial Officer

CARLSBAD, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE:ASG) announced the appointment of Jana F. Kiena as their Chief Financial Officer (CFO), effective December 17, 2019. Ms. Kiena will help guide and oversee the company’s continued market leadership and financial growth. She brings more than 25 …

ControlRad™ Announces Additions to Leadership Team

ATLANTA – December 17, 2019 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced several additions to its leadership team. Joining are Peter Pizzo as chief financial officer, Amy Lazarus as vice president of USA operations, Joe Ross as vice president …

Reactions to Congressional Repeal of Medical Device Excise Tax

by Elizabeth Hofheinz, M.P.H., M.Ed., December 17, 2019 It looks like roughly 21,000 American jobs are safe. An analysis by the nonpartisan Tax Foundation found that the return of the medical device excise tax would lead to a loss of 21,390 U.S. medical technology jobs and a $1.74 billion decline in the nation’s GDP.1 Today, …

Medical device tax on track for permanent repeal

December 16, 2019 / By NANCY CROTTI A bipartisan spending bill unveiled today by Congressional leaders would permanently repeal the 2.3% medical device excise tax. The spending bill, which must pass both houses of Congress and be signed by President Trump to take effect, would fulfill the widespread wishes of the medtech industry. The tax went …

MiMedx Announces Addition of Peter M. Carlson

MARIETTA, Ga., Dec. 16, 2019 /PRNewswire/ — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the addition of Peter M. Carlson as Executive Vice President, Finance, effective December 16, 2019. Mr. Carlson brings more than thirty years of comprehensive financial expertise having held …

Out-of-network billing by hospital-based specialists boosts spending by $40 billion

December 16, 2019 / SHELBY LIVINGSTON  Patients who seek care at in-network hospitals have a significant risk of being treated by and receiving a surprise bill from out-of-network anesthesiologists, pathologists, radiologists or assistant surgeons, a new study by Yale University researchers found. The ability of these four specialties to send patients out-of-network bills allowed them …

RTI Surgical® Announces The Spine Journal’s Publication of In Vivo TETRAfuse® 3D Technology PEKK Study

DEERFIELD, Ill., Dec. 17, 2019 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the publication of “A Comparative Study of Three Biomaterials in an Ovine Bone Defect Model: A TETRAfuse® PEKK Study” in The Spine Journal1. The study evaluated the in vivo material characteristics of Polyetheretherketone (PEEK), Titanium-coated PEEK …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1